Sarepta plans Elevidys shipments despite FDA request (SRPT) Seeking Alpha Sarepta Refuses FDA Request to Stop Shipping Muscular Dystrophy Drug Elevidys The New York Times FDA Requests Sarepta Therapeutics Suspend Distribution of Elevidys and Places Clinical Trials on Hold for Multiple Gene Therapy Products Following 3 Deaths fda.gov We are mothers of Duchenne patients. Recent setbacks with Sarepta must not stop progress statnews.com Sarepta …
Read More »